Authors: Gelsomino, S Frassani, R Porreca, L Livi, U

Citation: S. Gelsomino et al., Aortic repair in Marfan's syndrome: prevention of mechanical leaflets damage, CARDIOV SUR, 9(3), 2001, pp. 299-301

Authors: Gelsomino, S Frassani, R Morocutti, G Porreca, L Tursi, V Masullo, G Lumini, R Livi, U

Citation: S. Gelsomino et al., Left ventricular mass regression after aortic valve replacement with CryoLife-O'Brien stentless aortic bioprosthesis, J HEART V D, 10(5), 2001, pp. 603-610

Authors: Gelsomino, S Frassani, R Porreca, L Morocutti, G Morelli, A Livi, U

Citation: S. Gelsomino et al., Early and midterm results of model 300 CryoLife O'Brien stentless porcine aortic bioprosthesis, ANN THORAC, 71(5), 2001, pp. S297-S301

Authors: Gelsomino, S Frassani, R DaCol, P Porreca, L Masullo, G Morocutti, G Livi, U

Citation: S. Gelsomino et al., The CryoLife O'Brien stentless porcine aortic bioprosthesis: 5-year follow-up, ANN THORAC, 71(1), 2001, pp. 86-91

Authors: Pea, F Porreca, L Baraldo, M Furlanut, M

Citation: F. Pea et al., High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures, J ANTIMICRO, 45(3), 2000, pp. 329-335

Authors: Ranucci, M Mazzucco, A Pessotto, R Grillone, G Casati, V Porreca, L Maugeri, R Meli, M Magagna, P Cirri, S Giomarelli, P Lorusso, R de Jong, A

Citation: M. Ranucci et al., Heparin-coated circuits for high-risk patients: A multicenter, prospective, randomized trial, ANN THORAC, 67(4), 1999, pp. 994-1000